These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


279 related items for PubMed ID: 18058536

  • 1. A new family of inhibitors of Mycobacterium tuberculosis thymidine monophosphate kinase.
    Gasse C, Huteau V, Douguet D, Munier-Lehmann H, Pochet S.
    Nucleosides Nucleotides Nucleic Acids; 2007; 26(8-9):1057-61. PubMed ID: 18058536
    [No Abstract] [Full Text] [Related]

  • 2. Design of Mycobacterium tuberculosis thymidine monophosphate kinase inhibitors.
    Munier-Lehmann H, Pochet S, Dugue L, Dutruel O, Labesse G, Douget D.
    Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):801-4. PubMed ID: 14565282
    [No Abstract] [Full Text] [Related]

  • 3. Substituted benzyl-pyrimidines targeting thymidine monophosphate kinase of Mycobacterium tuberculosis: synthesis and in vitro anti-mycobacterial activity.
    Gasse C, Douguet D, Huteau V, Marchal G, Munier-Lehmann H, Pochet S.
    Bioorg Med Chem; 2008 Jun 01; 16(11):6075-85. PubMed ID: 18467107
    [Abstract] [Full Text] [Related]

  • 4. Rational design and 3D-pharmacophore mapping of 5'-thiourea-substituted alpha-thymidine analogues as mycobacterial TMPK inhibitors.
    Andrade CH, Pasqualoto KF, Ferreira EI, Hopfinger AJ.
    J Chem Inf Model; 2009 Apr 01; 49(4):1070-8. PubMed ID: 19296716
    [Abstract] [Full Text] [Related]

  • 5. Structure-aided design of inhibitors of Mycobacterium tuberculosis thymidylate kinase.
    Van Calenbergh S.
    Verh K Acad Geneeskd Belg; 2006 Apr 01; 68(4):223-48. PubMed ID: 17214439
    [Abstract] [Full Text] [Related]

  • 6. Discovery of bicyclic thymidine analogues as selective and high-affinity inhibitors of Mycobacterium tuberculosis thymidine monophosphate kinase.
    Vanheusden V, Munier-Lehmann H, Froeyen M, Busson R, Rozenski J, Herdewijn P, Van Calenbergh S.
    J Med Chem; 2004 Dec 02; 47(25):6187-94. PubMed ID: 15566289
    [Abstract] [Full Text] [Related]

  • 7. Drug design and identification of potent leads against mycobacterium tuberculosis thymidine monophosphate kinase.
    Van Calenbergh S, Pochet S, Munier-Lehmann H.
    Curr Top Med Chem; 2012 Dec 02; 12(7):694-705. PubMed ID: 22283813
    [Abstract] [Full Text] [Related]

  • 8. Exploring acyclic nucleoside analogues as inhibitors of Mycobacterium tuberculosis thymidylate kinase.
    Familiar O, Munier-Lehmann H, Negri A, Gago F, Douguet D, Rigouts L, Hernández AI, Camarasa MJ, Pérez-Pérez MJ.
    ChemMedChem; 2008 Jul 02; 3(7):1083-93. PubMed ID: 18418833
    [Abstract] [Full Text] [Related]

  • 9. A virtual screening approach for thymidine monophosphate kinase inhibitors as antitubercular agents based on docking and pharmacophore models.
    Gopalakrishnan B, Aparna V, Jeevan J, Ravi M, Desiraju GR.
    J Chem Inf Model; 2005 Jul 02; 45(4):1101-8. PubMed ID: 16045305
    [Abstract] [Full Text] [Related]

  • 10. Synthesis and evaluation of thymidine-5'-O-monophosphate analogues as inhibitors of Mycobacterium tuberculosis thymidylate kinase.
    Vanheusden V, Munier-Lehmann H, Pochet S, Herdewijn P, Van Calenbergh S.
    Bioorg Med Chem Lett; 2002 Oct 07; 12(19):2695-8. PubMed ID: 12217356
    [Abstract] [Full Text] [Related]

  • 11. 3'-C-branched-chain-substituted nucleosides and nucleotides as potent inhibitors of Mycobacterium tuberculosis thymidine monophosphate kinase.
    Vanheusden V, Munier-Lehmann H, Froeyen M, Dugué L, Heyerick A, De Keukeleire D, Pochet S, Busson R, Herdewijn P, Van Calenbergh S.
    J Med Chem; 2003 Aug 28; 46(18):3811-21. PubMed ID: 12930144
    [Abstract] [Full Text] [Related]

  • 12. Knowledge based identification of potent antitubercular compounds using structure based virtual screening and structure interaction fingerprints.
    Kumar A, Chaturvedi V, Bhatnagar S, Sinha S, Siddiqi MI.
    J Chem Inf Model; 2009 Jan 28; 49(1):35-42. PubMed ID: 19063713
    [Abstract] [Full Text] [Related]

  • 13. A prodrug approach for improving antituberculosis activity of potent Mycobacterium tuberculosis type II dehydroquinase inhibitors.
    Tizón L, Otero JM, Prazeres VF, Llamas-Saiz AL, Fox GC, van Raaij MJ, Lamb H, Hawkins AR, Ainsa JA, Castedo L, González-Bello C.
    J Med Chem; 2011 Sep 08; 54(17):6063-84. PubMed ID: 21780742
    [Abstract] [Full Text] [Related]

  • 14. 5-Arylaminouracil Derivatives: New Inhibitors of Mycobacterium tuberculosis.
    Matyugina E, Novikov M, Babkov D, Ozerov A, Chernousova L, Andreevskaya S, Smirnova T, Karpenko I, Chizhov A, Murthu P, Lutz S, Kochetkov S, Seley-Radtke KL, Khandazhinskaya AL.
    Chem Biol Drug Des; 2015 Dec 08; 86(6):1387-96. PubMed ID: 26061192
    [Abstract] [Full Text] [Related]

  • 15. Synthesis and biological activities of triazole derivatives as inhibitors of InhA and antituberculosis agents.
    Menendez C, Gau S, Lherbet C, Rodriguez F, Inard C, Pasca MR, Baltas M.
    Eur J Med Chem; 2011 Nov 08; 46(11):5524-31. PubMed ID: 21944473
    [Abstract] [Full Text] [Related]

  • 16. 3D-QSAR studies on antitubercular thymidine monophosphate kinase inhibitors based on different alignment methods.
    Aparna V, Jeevan J, Ravi M, Desiraju GR, Gopalakrishnan B.
    Bioorg Med Chem Lett; 2006 Feb 15; 16(4):1014-20. PubMed ID: 16290929
    [Abstract] [Full Text] [Related]

  • 17. Synthesis and evaluation of 5'-modified thymidines and 5-hydroxymethyl-2'-deoxyuridines as Mycobacterium tuberculosis thymidylate kinase inhibitors.
    Toti KS, Verbeke F, Risseeuw MD, Frecer V, Munier-Lehmann H, Van Calenbergh S.
    Bioorg Med Chem; 2013 Jan 01; 21(1):257-68. PubMed ID: 23199481
    [Abstract] [Full Text] [Related]

  • 18. 1-(Piperidin-3-yl)thymine amides as inhibitors of M. tuberculosis thymidylate kinase.
    Jian Y, Risseeuw MDP, Froeyen M, Song L, Cappoen D, Cos P, Munier-Lehmann H, van Calenbergh S.
    J Enzyme Inhib Med Chem; 2019 Dec 01; 34(1):1730-1739. PubMed ID: 31822127
    [Abstract] [Full Text] [Related]

  • 19. Elaboration of a proprietary thymidylate kinase inhibitor motif towards anti-tuberculosis agents.
    Song L, Risseeuw MDP, Froeyen M, Karalic I, Goeman J, Cappoen D, Van der Eycken J, Cos P, Munier-Lehmann H, Van Calenbergh S.
    Bioorg Med Chem; 2016 Nov 01; 24(21):5172-5182. PubMed ID: 27614917
    [Abstract] [Full Text] [Related]

  • 20. Thymidine and thymidine-5'-O-monophosphate analogues as inhibitors of Mycobacterium tuberculosis thymidylate kinase.
    Vanheusden V, Van Rompaey P, Munier-Lehmann H, Pochet S, Herdewijn P, Van Calenbergh S.
    Bioorg Med Chem Lett; 2003 Sep 15; 13(18):3045-8. PubMed ID: 12941330
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.